TC Biopharm (Holdings) Plc – NASDAQ:TCBPW

TC Biopharm (Holdings) stock price today

$0.006
-0.00
-40.43%
Financial Health
0
1
2
3
4
5
6
7
8
9

TC Biopharm (Holdings) stock price monthly change

-24.81%
month

TC Biopharm (Holdings) stock price quarterly change

-24.81%
quarter

TC Biopharm (Holdings) stock price yearly change

-56.71%
year

TC Biopharm (Holdings) key metrics

Market Cap
326.37K
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-22.38
Revenue
N/A
EBITDA
-22.03M
Income
-13.71M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

TC Biopharm (Holdings) stock price history

TC Biopharm (Holdings) stock forecast

TC Biopharm (Holdings) financial statements

TC Biopharm (Holdings) Plc (NASDAQ:TCBPW): Profit margin
Jun 2023 0 224.51K
Sep 2023 0 -3.81M
Dec 2023 0 -5.90M
Mar 2024 0 -4.21M
TC Biopharm (Holdings) Plc (NASDAQ:TCBPW): Debt to assets
Jun 2023 8229408 6.22M 75.61%
Sep 2023 8931664 6.24M 69.94%
Dec 2023 8931664 6.24M 69.94%
Mar 2024 7264053 6.18M 85.13%
TC Biopharm (Holdings) Plc (NASDAQ:TCBPW): Cash Flow
Jun 2023 -3.64M -71.59K 43.81K
Sep 2023 0 0 0
Dec 2023 -10.54M -208.78K 8.52M
Mar 2024 -3.05M -7.12K 1.18M

TC Biopharm (Holdings) alternative data

TC Biopharm (Holdings) Plc (NASDAQ:TCBPW): Employee count
Aug 2023 74
Sep 2023 74
Oct 2023 74
Nov 2023 74
Dec 2023 74
Jan 2024 60
Feb 2024 60
Mar 2024 60
Apr 2024 60
May 2024 41
Jun 2024 41
Jul 2024 41

TC Biopharm (Holdings) other data

  • What's the price of TC Biopharm (Holdings) stock today?

    One share of TC Biopharm (Holdings) stock can currently be purchased for approximately $0.01.

  • When is TC Biopharm (Holdings)'s next earnings date?

    Unfortunately, TC Biopharm (Holdings)'s (TCBPW) next earnings date is currently unknown.

  • Does TC Biopharm (Holdings) pay dividends?

    No, TC Biopharm (Holdings) does not pay dividends.

  • How much money does TC Biopharm (Holdings) make?

    TC Biopharm (Holdings) has a market capitalization of 326.37K.

  • What is TC Biopharm (Holdings)'s stock symbol?

    TC Biopharm (Holdings) Plc is traded on the NASDAQ under the ticker symbol "TCBPW".

  • What is TC Biopharm (Holdings)'s primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of TC Biopharm (Holdings)?

    Shares of TC Biopharm (Holdings) can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does TC Biopharm (Holdings) have?

    As Jul 2024, TC Biopharm (Holdings) employs 41 workers, which is 32% less then previous quarter.

  • What is TC Biopharm (Holdings)'s official website?

    The official website for TC Biopharm (Holdings) is tcbiopharm.com.

  • How can i contact TC Biopharm (Holdings)?

    TC Biopharm (Holdings) can be reached via phone at +44 141 433 7557.

TC Biopharm (Holdings) company profile:

TC Biopharm (Holdings) Plc

tcbiopharm.com
Exchange:

NASDAQ

Full time employees:

41

Industry:

Biotechnology

Sector:

Healthcare

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Maxim 1
Motherwell, ML1 4WR

CIK: 0001872812
ISIN: US87807D1110
CUSIP: 87807D111